Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 6:31 pm Purchase | 2025-12-31 | 13G | Inventiva S.A. IVA | Andera Partners | 14,114,476 7.700% | 1,818,181 (+14.79%) | Filing History |
| 2025-11-17 4:33 pm Purchase | 2025-11-07 | 13G | Evommune, Inc. EVMN | Andera Partners | 1,897,362 6.000% | 1,897,362 (New Position) | Filing History |
| 2025-08-14 4:13 pm Sale | 2025-06-30 | 13G | Mineralys Therapeutics, Inc. MLYS | Andera Partners | 2,765,976 4.200% | -100,000 (-3.49%) | Filing History |
| 2025-08-14 4:13 pm Purchase | 2025-06-30 | 13G | Inventiva S.A. IVA | Andera Partners | 12,296,295 8.800% | 6,148,148 (+100.00%) | Filing History |
| 2025-04-14 6:13 pm Purchase | 2024-10-17 | 13G | Inventiva S.A. IVA | Andera Partners | 6,148,147 6.500% | 6,148,147 (New Position) | Filing History |
| 2023-02-24 4:01 pm Purchase | 2023-02-14 | 13G | Mineralys Therapeutics, Inc. MLYS | Andera Partners | 2,865,976 7.000% | 2,865,976 (New Position) | Filing History |
| 2022-10-20 08:54 am Purchase | 2020-12-31 | 13G | ContextLogic Inc. LOGC | Andera Partners | 76,247 7.200% | 16,650 (+27.94%) | Filing History |